GlassScriptPhysician profile
Leigh J Hess
NPI 1811342181
$3,731.57
in general payments reported to CMS, 2019-2025
11 companies · $3,602 in 2025
The $3,602 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.50 · 2023: $64.28 · 2024: $18.04 · 2025: $3,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,866 · Education: $1,500 · Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,866.06 |
| Education | $1,500.00 |
| Food and Beverage | $318.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,498.92 | 2025 | |
| Exeltis, USA INC. | $45.91 | 2023 | Slynd |
| Hologic Sales and Service, LLC | $29.62 | 2025 | Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $25.68 | 2025 | |
| Pfizer INC. | $25.26 | 2025 | |
| Astellas Pharma US INC | $22.27 | 2025 | Veozah |
| Evofem Biosciences, INC. | $18.96 | 2022 | |
| Abbvie INC. | $18.37 | 2023 | |
| Conmed Corporation | $18.04 | 2024 | Visiclear, Airseal, Vcare |
| Organon LLC | $16.27 | 2022 | |
| Therapeuticsmd, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.